Status:
RECRUITING
Prognosis of Paroxysmal Kinesigenic Choreoathetosis in Korea
Lead Sponsor:
Seoul National University Hospital
Conditions:
Paroxysmal Kinesigenic Choreoathetosis
Eligibility:
All Genders
18+ years
Brief Summary
The aim of this study is to assess the prognosis of paroxysmal kinesigenic choreoathetosis (PKC) in Korean.
Detailed Description
PKC is a hyperkinetic movement disorder including dystonia, chorea, athetosis, or ballism, which are characteristically triggered by a sudden movement from rest. The prevalence of this disorder is est...
Eligibility Criteria
Inclusion
- Male or female PKC patients who were18 years of age and older
- Subjects were diagnosed as paroxysmal kinesigenic choreoathetosis (PKC)
- Subjects were enrolled voluntarily and understood the contents of this trial
Exclusion
- Existence of lesions on the brain
- Existence of neurological deficit that suspected lesions on the brain
- Existence of epileptiform discharges on electroencephalogram
- Subjects with secondary PKC which was caused by other disorder or illness
- Existence of illness or problems which made difficult to be enrolled to this trial judged by clinicians
Key Trial Info
Start Date :
November 11 2016
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04023656
Start Date
November 11 2016
End Date
December 31 2026
Last Update
July 17 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Hospital
Seoul, South Korea, 03080